Accumulation of dysfunctional tumor-infiltrating PD-1+ DCs links PD-1/PD-L1 blockade immunotherapeutic response in cervical cancer-Reference-Cited by-同舟云学术

Accumulation of dysfunctional tumor-infiltrating PD-1+ DCs links PD-1/PD-L1 blockade immunotherapeutic response in cervical cancer

Published:2022-02-09 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Wang Yu-meng¹²,Qiu Jun-jun¹²,Qu Xin-yu¹²,Peng Jing²³,Lu Chong²³,Zhang Meng²³,Zhang Ming-Xing²³,Qi Xing-ling²³,Lv Bin¹²,Guo Jing-Jing¹²,Guo Chen-yan¹²,Li Gui-ling²³,Hua Ke-qin¹²

Affiliation:

1. Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China

2. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China

3. Department of Integration of Western and Traditional Medicine, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shanghai Science and Technology

Shanghai “Rising Stars of Medical Talent” Youth Development Program

Clinical Research Plan of SHDC

Shanghai Municipal Health Commission

Research and Innovation Project of the Shanghai Municipal Education Commission

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2034257

Reference50 articles.

1. Cancer statistics, 2020

2. Relation of human papilloma virus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

3. Immunotherapy in cervix cancer

4. Cervical Cancer Immunotherapy: Facts and Hopes

5. Innate immune mediators in cancer: between defense and resistance

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy;Journal for ImmunoTherapy of Cancer;2024-08

2. PD‐1: A critical player and target for immune normalization;Immunology;2024-01-25

3. SLC35A2 expression drives breast cancer progression via ERK pathway activation;The FEBS Journal;2024-01-09

4. Necroptosis-associated long noncoding RNA predicts prognosis for cervical cancer in a microenvironment signature associated with anti-tumor immune responses;2023-10-12

5. Characterization of the microenvironment in different immune-metabolism subtypes of cervical cancer with prognostic significance;Frontiers in Genetics;2023-02-03